<PAGE>
WASHINGTON, D.C. 20549
Quarterly Report Under Section 13 or 15 (d)
of the Securities Exchange Act of 1934
10-Q/A2
For Quarter Ended: December 31, 1996
Commission File Number 001-12106
AMBI INC.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 11-2653613
- ----------------------------------------------------------------------------
(State or other jurisdiction of (IRS Employer Identification Number)
incorporation of organization)
771 Old Saw Mill River Road, Tarrytown, New York 10591
- ----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(914) 347-5767
- ----------------------------------------------------------------------------
(Registrant's telephone number, including area code)
APPLIED MICROBIOLOGY, INC.
- ----------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
YES X NO _______
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Common Stock, Par Value $.005 18,425,374 shares as of December 31, 1996
- ----------------------------- -----------------------------------------
<PAGE>
AMBI INC.
Part I, Item 1 FINANCIAL INFORMATION
This amendment on Form 10-Q/A2 is being filed to amend the Condensed
Consolidated Statement of Cash Flows which are set forth in full below.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Six Months Ended
December 31
1996 1995
$'000 $'000
----- -----
Cash flows from operating activities:
Net income/(loss) 2,474 (1,844)
Adjustments to reconcile net income/(loss)
to net cash used in operating activities:
Depreciation and amortization 483 358
Gain on Sale of Aplin & Barrett (9,683) -
Other non-cash items 65 96
Changes in assets and liabilities,
net of effects from sale of subsidiary:
(Increase)/decrease in trade accounts receivable (635) 41
Decrease(increase) in inventories 275 (172)
(Increase) in other assets (209) (372)
(Increase) in amounts due from
affiliated companies - (155)
(Decrease)/increase in taxes payable (254) 54
(Decrease) in accounts payable and
accrued expenses 1,147 (513)
Increase in amounts due to
affiliated companies - 13
Increase in other liabilities 189 3
------- ------
Net cash (used in) operating activities (6,148) (2,491)
------- ------
Cash flows from investing activities:
Acquisitions of property and equipment (754) (744)
Patent costs and licensed technology (121) (395)
Cash received upon sale of subsidiary 8,000 -
------- ------
Net cash provided by/(used in) investing activities 7,125 (1,139)
------- ------
Cash flows from financing activities:
Dividends paid on redeemable preferred stock - (69)
Note payable proceeds - 35
Capital lease proceeds 328 389
Note payable repayments - (4)
Capital lease obligation repayments (1,103) (79)
Proceeds from issuance of convertible
preferred stock - 8,213
Proceeds from issuance of common stock 294 375
------- ------
Net cash (used in)/provided by financing activities (481) 8,860
------- ------
Effect of exchange rate movement (10) (19)
<PAGE>
AMBI INC.
Net increase in cash and cash equivalents 486 5,211
Cash and cash equivalents at beginning of period 8,431 3,337
------- ------
Cash and cash equivalents at end of period 8,917 8,548
======= ======
Supplementary disclosure of cash flow information:
Interest paid 62 4
Tax paid 0 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
AMBI INC.
Registrant
Date: March 27, 1998 By: /s/ Fredric D. Price
-------------------------
Fredric D. Price
President and Chief Executive Officer
